Get the Stockscreener App
20.02
0.25%
-0.05
After Hours:
20.25
0.23
+1.15%
Catalyst Pharmaceuticals Inc stock is traded at $20.02, with a volume of 984.63K.
It is down -0.25% in the last 24 hours and down -1.04% over the past month.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
See More
Previous Close:
$20.07
Open:
$20.21
24h Volume:
984.63K
Relative Volume:
0.69
Market Cap:
$2.45B
Revenue:
$460.48M
Net Income/Loss:
$142.80M
P/E Ratio:
16.97
EPS:
1.18
Net Cash Flow:
$221.79M
1W Performance:
+1.42%
1M Performance:
-1.04%
6M Performance:
-8.21%
1Y Performance:
-2.05%
1-Day Range:
$19.94
$20.42
1-Week Range:
$19.66
$20.52
52-Week Range:
$19.15
$26.58
Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile
Name
Catalyst Pharmaceuticals Inc
Sector
Industry
Phone
(305) 529-2522
Address
355 ALHAMBRA CIRCLE, CORAL GABLES
Compare CPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPRX
Catalyst Pharmaceuticals Inc
|
20.02 | 2.46B | 460.48M | 142.80M | 221.79M | 1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Initiated | Robert W. Baird | Outperform |
| Nov-18-24 | Initiated | Stephens | Overweight |
| Mar-14-24 | Initiated | Citigroup | Buy |
| Mar-07-24 | Initiated | BofA Securities | Buy |
| Dec-21-23 | Initiated | Oppenheimer | Outperform |
| Aug-24-22 | Downgrade | ROTH Capital | Buy → Neutral |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-07-18 | Resumed | Piper Jaffray | Overweight |
| Oct-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-26-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Sep-30-14 | Reiterated | ROTH Capital | Buy |
| Sep-16-14 | Reiterated | ROTH Capital | Buy |
| Sep-15-14 | Reiterated | H.C. Wainwright | Buy |
| Oct-21-13 | Reiterated | Aegis Capital | Buy |
| Sep-24-13 | Initiated | Maxim Group | Buy |
| Sep-06-13 | Reiterated | Aegis Capital | Buy |
| Apr-18-13 | Initiated | Aegis Capital | Buy |
| Aug-27-12 | Upgrade | Rodman & Renshaw | Mkt Perform → Mkt Outperform |
| Oct-01-09 | Upgrade | Merriman | Sell → Neutral |
| May-29-09 | Downgrade | Hapoalim | Neutral → Underperform |
| May-29-09 | Downgrade | Merriman Curhan Ford | Buy → Sell |
| Dec-15-08 | Initiated | Merriman Curhan Ford | Buy |
| Nov-28-07 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jan-31-07 | Initiated | Stifel Nicolaus | Buy |
| Jan-05-07 | Initiated | First Albany | Buy |
View All
Catalyst Pharmaceuticals Inc Stock (CPRX) Latest News
Aug PreEarnings: Can Catalyst Pharmaceuticals Inc stock outperform in a bear market2025 AllTime Highs & Real-Time Chart Pattern Alerts - خودرو بانک
Catalyst Pharmaceuticals (NASDAQ:CPRX) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Woodline Partners LP Cuts Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Wesbanco Bank Inc. Has $1.22 Million Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
AQR Capital Management LLC Sells 31,501 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Rally Mode: Is Catalyst Pharmaceuticals Inc a top pick in the sectorEarnings Growth Report & Free Fast Entry Momentum Trade Alerts - خودرو بانک
What is the next catalyst for CASI Pharmaceuticals IncMarket Trend Review & Technical Pattern Recognition Alerts - خودرو بانک
Chart Watch: Is Catalyst Pharmaceuticals Inc currently under institutional pressureJuly 2025 Action & Daily Profit Focused Screening - خودرو بانک
Ideas Watch: Will Catalyst Pharmaceuticals Inc benefit from government policyWeekly Risk Report & Stepwise Trade Execution Plans - خودرو بانک
Richard P Slaughter Associates Inc Sells 54,614 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Fred Alger Management LLC Buys Shares of 51,402 Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Swedbank AB Makes New $14.94 Million Investment in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Insider Selling: Catalyst Pharmaceuticals (NASDAQ:CPRX) Insider Sells 30,000 Shares of Stock - MarketBeat
Sentiment Review: Is Catalyst Pharmaceuticals Inc. a momentum stockForecast Cut & Weekly Chart Analysis and Trade Guides - خودرو بانک
Signal Recap: Should I trade or invest in Catalyst Pharmaceuticals IncGold Moves & Weekly Top Performers Watchlists - خودرو بانک
Technical Analysis: How is Catalyst Pharmaceuticals Inc. managing supply chain issues2025 Performance Recap & Community Trade Idea Sharing Platform - خودرو بانک
Catalyst Pharmaceutical (CPRX) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Top chart patterns to watch in Catalyst Pharmaceuticals Inc.Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Jacobs Levy Equity Management Inc. Sells 406,554 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Rating of "Buy" by Analysts - MarketBeat
Advisors Asset Management Inc. Has $4.34 Million Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
21,083 Shares in Catalyst Pharmaceuticals, Inc. $CPRX Purchased by Nomura Holdings Inc. - MarketBeat
Catalyst Pharmaceuticals, Inc. $CPRX Shares Purchased by Clark Capital Management Group Inc. - MarketBeat
New Vernon Capital Holdings II LLC Raises Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Is Catalyst Pharmaceuticals Inc.’s growth already priced inMarket Movement Recap & Long-Term Safe Investment Plans - Lancaster City Council
Is Catalyst Pharmaceuticals Inc. stock a falling knife or bargain buy2025 Macro Impact & Low Risk High Win Rate Stock Picks - Lancaster City Council
Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin - MSN
Is Catalyst Pharmaceuticals Inc. impacted by rising ratesIndex Update & Verified Momentum Stock Alerts - 뉴스영
State of Wyoming Reduces Stock Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Published on: 2025-09-07 06:18:36 - 뉴스영
What momentum shifts mean for Catalyst Pharmaceuticals Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - Newser
Is Catalyst Pharmaceuticals Inc. gaining market shareBull Run & Free Technical Confirmation Trade Alerts - classian.co.kr
Trexquant Investment LP Increases Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Investors Don't See Light At End Of Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Tunnel - 富途牛牛
Catalyst Pharmaceuticals settles lawsuit with Lupin - MSN
What is the next catalyst for Zentalis Pharmaceuticals Inc.Trade Risk Summary & Verified Momentum Watchlists - خودرو بانک
Can Catalyst Pharmaceuticals Inc. maintain sales growthEarnings Recap Summary & AI Enhanced Trading Signals - خودرو بانک
Is Now a Good Time to Reenter Catalyst Pharmaceuticals Inc.2025 Support & Resistance & Technical Buy Zone Confirmations - beatles.ru
Published on: 2025-09-05 17:12:37 - beatles.ru
Catalyst Pharmaceuticals, Inc. $CPRX Shares Bought by Raymond James Financial Inc. - MarketBeat
Using R and stats models for Catalyst Pharmaceuticals Inc. forecastingQuarterly Portfolio Review & Low Risk High Win Rate Picks - Newser
How high can Catalyst Pharmaceuticals Inc. stock go2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
Catalyst Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Decliners & Community Trade Idea Sharing Platform - Newser
How to recover losses in Catalyst Pharmaceuticals Inc. stockJuly 2025 Sentiment & Expert Curated Trade Ideas - Newser
Catalyst Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Institutional & Real-Time Chart Pattern Alerts - Newser
Smart tools for monitoring Catalyst Pharmaceuticals Inc.’s price actionPortfolio Performance Summary & AI Forecasted Entry/Exit Points - Newser
What is the next catalyst for Mirum Pharmaceuticals Inc.Trade Risk Report & Safe Capital Growth Stock Tips - khodrobank.com
Can Catalyst Pharmaceuticals Inc. outperform in the next rallyMarket Rally & Free Safe Entry Trade Signal Reports - خودرو بانک
Catalyst Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 News Drivers & Expert-Curated Trade Recommendations - Newser
Is Catalyst Pharmaceuticals Inc. reversing from oversold territoryBull Run & Real-Time Chart Breakout Alerts - Newser
News impact scoring models applied to Catalyst Pharmaceuticals Inc.July 2025 PostEarnings & Safe Capital Investment Plans - Newser
Catalyst Pharmaceuticals Inc Stock (CPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):